No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 3fcsD, 0.9420, 1.53, 0.105, 603, 239, STRUCTURE OF COMPLETE ECTODOMAIN OF INTEGRIN AIIBB3
2, 3fcsB, 0.9414, 1.54, 0.105, 680, 239, STRUCTURE OF COMPLETE ECTODOMAIN OF INTEGRIN AIIBB3
3, 3zdxD, 0.9409, 1.56, 0.105, 469, 239, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
4, 3zdxB, 0.9407, 1.56, 0.105, 464, 239, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
5, 3v4vD, 0.9405, 1.44, 0.134, 375, 238, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
6, 3v4vB, 0.9405, 1.44, 0.134, 375, 238, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
7, 3t3pB, 0.9405, 1.56, 0.105, 466, 239, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
8, 3nigB, 0.9405, 1.56, 0.105, 466, 239, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
9, 4g1mB, 0.9404, 1.55, 0.105, 692, 239, RE-REFINEMENT OF ALPHA V BETA 3 STRUCTURE
10, 3v4pB, 0.9404, 1.45, 0.134, 375, 238, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
11, 3t3mB, 0.9404, 1.57, 0.105, 466, 239, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
12, 3nidB, 0.9404, 1.56, 0.105, 466, 239, THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
13, 3nifB, 0.9403, 1.56, 0.105, 466, 239, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
14, 3nidD, 0.9403, 1.56, 0.105, 471, 239, THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
15, 3v4pD, 0.9402, 1.46, 0.130, 375, 238, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
16, 3t3pD, 0.9402, 1.57, 0.105, 471, 239, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
17, 3nigD, 0.9399, 1.57, 0.105, 471, 239, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
18, 3t3mD, 0.9398, 1.57, 0.105, 471, 239, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
19, 3nifD, 0.9397, 1.57, 0.105, 467, 239, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
20, 3zdyD, 0.9396, 1.58, 0.105, 469, 239, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
21, 4g1eB, 0.9393, 1.59, 0.105, 709, 239, CRYSTAL STRUCTURE OF INTEGRIN ALPHA V BETA 3 WITH COIL-COILED TAG.
22, 3zdzD, 0.9392, 1.58, 0.105, 469, 239, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
23, 4z7nD, 0.9387, 1.59, 0.105, 469, 239, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
24, 3zdyB, 0.9387, 1.59, 0.105, 464, 239, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
25, 4z7qD, 0.9386, 1.58, 0.105, 471, 239, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE
26, 4um9B, 0.9385, 1.55, 0.126, 448, 239, CRYSTAL STRUCTURE OF ALPHA V BETA 6 WITH PEPTIDE
27, 4um9D, 0.9383, 1.56, 0.126, 455, 239, CRYSTAL STRUCTURE OF ALPHA V BETA 6 WITH PEPTIDE
28, 4z7qB, 0.9381, 1.59, 0.105, 466, 239, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE
29, 4o02B, 0.9380, 1.56, 0.105, 687, 239, ALPHAVBETA3 INTEGRIN IN COMPLEX WITH MONOCLONAL ANTIBODY FAB FRAGMENT.
30, 4z7oD, 0.9377, 1.60, 0.105, 469, 239, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
31, 4mmzB, 0.9377, 1.59, 0.105, 690, 239, INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO AN ANTAGONISTIC TENTH DOMAIN OF FIBRONECTIN
32, 5hdbD, 0.9373, 1.60, 0.105, 471, 239, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054
33, 5hdbB, 0.9367, 1.61, 0.105, 466, 239, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054
34, 3ze0D, 0.9364, 1.61, 0.105, 469, 239, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
35, 3ijeB, 0.9355, 1.56, 0.109, 695, 238, CRYSTAL STRUCTURE OF THE COMPLETE INTEGRIN ALHAVBETA3 ECTODOMAIN PLUS AN ALPHA/BETA TRANSMEMBRANE FRAGMENT
36, 3ze1D, 0.9352, 1.62, 0.105, 469, 239, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
37, 4z7oB, 0.9337, 1.65, 0.105, 464, 239, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
38, 1u8cB, 0.9337, 1.59, 0.109, 599, 238, A NOVEL ADAPTATION OF THE INTEGRIN PSI DOMAIN REVEALED FROM ITS CRYSTAL STRUCTURE
39, 5ffgB, 0.9336, 1.66, 0.126, 248, 239, CRYSTAL STRUCTURE OF INTEGRIN ALPHA V BETA 6 HEAD
40, 4um8B, 0.9336, 1.66, 0.126, 423, 239, CRYSTAL STRUCTURE OF ALPHA V BETA 6
41, 1jv2B, 0.9335, 1.58, 0.113, 539, 238, CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN ALPHAVBETA3
42, 3ze2B, 0.9334, 1.65, 0.105, 469, 239, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
43, 4um8D, 0.9327, 1.68, 0.126, 414, 239, CRYSTAL STRUCTURE OF ALPHA V BETA 6
44, 5netB, 0.9326, 1.51, 0.127, 448, 237, LOCALISED RECONSTRUCTION OF INTEGRIN ALPHA V BETA 6 BOUND TO FOOT AND MOUTH DISEASE VIRUS O1 MANISA - POSE A.
45, 5nerB, 0.9326, 1.51, 0.127, 448, 237, LOCALISED RECONSTRUCTION OF ALPHA V BETA 6 BOUND TO FOOT AND MOUTH DISEASE VIRUS O PANASIA - POSE A PRIME.
46, 5nemB, 0.9326, 1.51, 0.127, 448, 237, LOCALISED RECONSTRUCTION OF ALPHA V BETA 6 BOUND TO FOOT AND MOUTH DISEASE VIRUS O PANASIA - POSE A.
47, 1m1xB, 0.9324, 1.61, 0.113, 539, 238, CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN ALPHA VBETA3 BOUND TO MN2+
48, 4wk0B, 0.9319, 1.46, 0.131, 427, 236, METAL ION AND LIGAND BINDING OF INTEGRIN
49, 5e6uB, 0.9317, 1.51, 0.105, 453, 237, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
50, 5e6sF, 0.9313, 1.51, 0.105, 455, 237, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
51, 5e6sD, 0.9311, 1.52, 0.105, 455, 237, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
52, 4wjkB, 0.9311, 1.47, 0.131, 424, 236, METAL ION AND LIGAND BINDING OF INTEGRIN
53, 5e6rB, 0.9309, 1.52, 0.105, 454, 237, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
54, 3vi3D, 0.9305, 1.48, 0.131, 432, 236, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
55, 6avuB, 0.9299, 1.65, 0.109, 461, 239, HUMAN ALPHA-V BETA-3 INTEGRIN (OPEN CONFORMATION) IN COMPLEX WITH THE THERAPEUTIC ANTIBODY LM609
56, 4wk2B, 0.9299, 1.49, 0.131, 427, 236, METAL ION AND LIGAND BINDING OF INTEGRIN
57, 4nenB, 0.9294, 1.54, 0.101, 665, 237, AN INTERNAL LIGAND-BOUND METASTABLE STATE OF A LEUKOCYTE INTEGRIN AXB2
58, 3vi3B, 0.9292, 1.50, 0.131, 427, 236, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
59, 5e6sB, 0.9291, 1.55, 0.105, 455, 237, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
60, 4wk4B, 0.9289, 1.50, 0.131, 435, 236, METAL ION AND LIGAND BINDING OF INTEGRIN
61, 6avrB, 0.9287, 1.67, 0.109, 685, 239, HUMAN ALPHA-V BETA-3 INTEGRIN (INTERMEDIATE CONFORMATION) IN COMPLEX WITH THE THERAPEUTIC ANTIBODY LM609
62, 6avqB, 0.9287, 1.68, 0.109, 688, 239, THE THERAPEUTIC ANTIBODY LM609 SELECTIVELY INHIBITS LIGAND BINDING TO HUMAN ALPHA-V BETA-3 INTEGRIN VIA STERIC HINDRANCE
63, 3vi4B, 0.9285, 1.51, 0.131, 431, 236, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE
64, 3vi4D, 0.9284, 1.50, 0.127, 433, 236, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE
65, 5es4F, 0.9247, 1.62, 0.101, 674, 237, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
66, 5es4B, 0.9229, 1.61, 0.101, 674, 237, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
67, 5es4D, 0.9201, 1.65, 0.101, 674, 237, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
68, 5es4H, 0.9194, 1.68, 0.105, 674, 237, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
69, 4nehB, 0.9173, 1.71, 0.101, 668, 237, AN INTERNAL LIGAND-BOUND METASTABLE STATE OF A LEUKOCYTE INTEGRIN AXB2
70, 5neuB, 0.9158, 1.85, 0.126, 448, 238, LOCALISED RECONSTRUCTION OF INTEGRIN ALPHA V BETA 6 BOUND TO FOOT AND MOUTH DISEASE VIRUS O1 MANISA - POSE B.
71, 4z7nB, 0.9152, 2.15, 0.105, 464, 239, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
72, 3zdzB, 0.9138, 2.15, 0.105, 464, 239, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
73, 3k71H, 0.9138, 1.73, 0.105, 673, 237, STRUCTURE OF INTEGRIN ALPHAX BETA2 ECTODOMAIN
74, 3k71F, 0.9138, 1.73, 0.105, 673, 237, STRUCTURE OF INTEGRIN ALPHAX BETA2 ECTODOMAIN
75, 3k71D, 0.9138, 1.73, 0.105, 673, 237, STRUCTURE OF INTEGRIN ALPHAX BETA2 ECTODOMAIN
76, 3k71B, 0.9138, 1.73, 0.105, 673, 237, STRUCTURE OF INTEGRIN ALPHAX BETA2 ECTODOMAIN
77, 3k6sD, 0.9138, 1.72, 0.105, 674, 237, STRUCTURE OF INTEGRIN ALPHAXBETA2 ECTODOMAIN
78, 3k6sH, 0.9137, 1.72, 0.105, 674, 237, STRUCTURE OF INTEGRIN ALPHAXBETA2 ECTODOMAIN
79, 3k72B, 0.9136, 1.73, 0.105, 673, 237, STRUCTURE OF INTEGRIN ALPHAX BETA2
80, 3k6sF, 0.9136, 1.73, 0.105, 674, 237, STRUCTURE OF INTEGRIN ALPHAXBETA2 ECTODOMAIN
81, 3k6sB, 0.9136, 1.73, 0.105, 674, 237, STRUCTURE OF INTEGRIN ALPHAXBETA2 ECTODOMAIN
82, 3k72D, 0.9135, 1.73, 0.105, 673, 237, STRUCTURE OF INTEGRIN ALPHAX BETA2
83, 3ze1B, 0.9134, 2.15, 0.105, 464, 239, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
84, 3ze0B, 0.9133, 2.16, 0.105, 465, 239, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
85, 1l5gB, 0.9095, 1.98, 0.109, 539, 239, CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN AVB3 IN COMPLEX WITH AN ARG-GLY-ASP LIGAND
86, 4mmyB, 0.9078, 2.13, 0.109, 690, 239, INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO THE TENTH DOMAIN OF FIBRONECTIN WITH THE IAKGDWND MOTIF
87, 4mmxB, 0.9076, 2.15, 0.109, 690, 239, INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO THE TENTH DOMAIN OF FIBRONECTIN
88, 5ffoB, 0.8939, 2.00, 0.106, 242, 236, INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA
89, 5ffoF, 0.8936, 2.01, 0.106, 242, 236, INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA
90, 3fcuF, 0.8882, 2.00, 0.094, 455, 235, STRUCTURE OF HEADPIECE OF INTEGRIN AIIBB3 IN OPEN CONFORMATION
91, 3fcuD, 0.8882, 2.03, 0.094, 455, 235, STRUCTURE OF HEADPIECE OF INTEGRIN AIIBB3 IN OPEN CONFORMATION
92, 3fcuB, 0.8877, 2.04, 0.094, 455, 235, STRUCTURE OF HEADPIECE OF INTEGRIN AIIBB3 IN OPEN CONFORMATION
93, 1tyeD, 0.8877, 2.03, 0.094, 440, 235, STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND- MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN
94, 3ze2D, 0.8868, 2.02, 0.094, 367, 235, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
95, 1tyeF, 0.8866, 2.03, 0.094, 440, 235, STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND- MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN
96, 2vdrB, 0.8861, 2.07, 0.094, 455, 235, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE LGGAKQRGDV
97, 2vdqB, 0.8859, 2.07, 0.094, 455, 235, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE HHLGGAKQRGDV
98, 2vdoB, 0.8859, 2.07, 0.094, 455, 235, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDE HHLGGAKQAGDV
99, 2vc2B, 0.8859, 2.07, 0.094, 457, 235, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST L-739758
100, 2vdpB, 0.8858, 2.07, 0.094, 455, 235, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDELGGAKQAGDV
101, 2vdkB, 0.8857, 2.07, 0.094, 455, 235, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
102, 1tyeB, 0.8855, 2.03, 0.094, 440, 235, STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND- MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN
103, 2vdlB, 0.8853, 2.08, 0.094, 456, 235, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
104, 2vdnB, 0.8852, 2.08, 0.094, 455, 235, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST EPTIFIBATIDE
105, 2vdmB, 0.8851, 2.08, 0.094, 456, 235, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST TIROFIBAN
106, 6djpB, 0.8596, 1.72, 0.126, 353, 222, INTEGRIN ALPHA-V BETA-8 IN COMPLEX WITH THE FABS 8B8 AND 68 
107, 2iueA, 0.7772, 1.99, 0.093, 212, 205, PACTOLUS I-DOMAIN: FUNCTIONAL SWITCHING OF THE ROSSMANN FOLD
108, 4cakB, 0.7662, 2.63, 0.124, 680, 210, THREE-DIMENSIONAL RECONSTRUCTION OF INTACT HUMAN INTEGRIN ALPHAIIBBETA3 IN A PHOSPHOLIPID BILAYER NANODISC
109, 2ww8A, 0.6253, 4.43, 0.100, 815, 209, STRUCTURE OF THE PILUS ADHESIN (RRGA) FROM STREPTOCOCCUS PNEUMONIAE
110, 3tvyA, 0.6201, 4.51, 0.096, 365, 209, STRUCTURAL ANALYSIS OF ADHESIVE TIP PILIN GBS104 FROM GROUP B STREPTOCOCCUS AGALACTIAE
111, 3txaA, 0.6188, 4.42, 0.097, 583, 207, STRUCTURAL ANALYSIS OF ADHESIVE TIP PILIN GBS104 FROM GROUP B STREPTOCOCCUS AGALACTIAE
112, 6fvwCA, 0.6110, 2.62, 0.087, 197, 172, struct.pdbx_descriptor              
113, 4cn9B, 0.6104, 2.97, 0.131, 396, 176, STRUCTURE OF PROXIMAL THREAD MATRIX PROTEIN 1 (PTMP1) FROM THE MUSSEL BYSSUS WITH ZINC OCCUPIED MIDAS MOTIF
114, 4cnbB, 0.6093, 3.01, 0.131, 391, 176, STRUCTURE OF PROXIMAL THREAD MATRIX PROTEIN 1 (PTMP1) FROM THE MUSSEL BYSSUS - CRYSTAL FORM 2
115, 4cn9A, 0.6091, 2.99, 0.131, 397, 176, STRUCTURE OF PROXIMAL THREAD MATRIX PROTEIN 1 (PTMP1) FROM THE MUSSEL BYSSUS WITH ZINC OCCUPIED MIDAS MOTIF
116, 4cnbA, 0.6087, 3.02, 0.131, 387, 176, STRUCTURE OF PROXIMAL THREAD MATRIX PROTEIN 1 (PTMP1) FROM THE MUSSEL BYSSUS - CRYSTAL FORM 2
117, 4cn8A, 0.6075, 3.04, 0.131, 392, 176, STRUCTURE OF PROXIMAL THREAD MATRIX PROTEIN 1 (PTMP1) FROM THE MUSSEL BYSSUS
118, 5mpcIA, 0.6069, 2.87, 0.086, 197, 174, 
119, 6fvyCA, 0.6063, 2.81, 0.087, 197, 173, struct.pdbx_descriptor              
120, 6fvuCA, 0.6056, 2.76, 0.087, 197, 172, struct.pdbx_descriptor              
121, 6fvvCA, 0.6046, 2.89, 0.092, 197, 174, struct.pdbx_descriptor              
122, 5mpeW, 0.6024, 2.92, 0.092, 197, 174, 26S PROTEASOME IN PRESENCE OF ATP (S2)
123, 1sq0A, 0.6013, 3.26, 0.124, 198, 177, CRYSTAL STRUCTURE OF THE COMPLEX OF THE WILD-TYPE VON WILLEBRAND FACTOR A1 DOMAIN AND GLYCOPROTEIN IB ALPHA AT 2.6 ANGSTROM RESOLUTION
124, 6fvxCA, 0.6005, 2.89, 0.087, 197, 173, struct.pdbx_descriptor              
125, 4cr4W, 0.5994, 2.84, 0.104, 197, 173, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
126, 3jcpFA, 0.5994, 3.04, 0.103, 197, 175, 
127, 1fnsA, 0.5992, 3.20, 0.125, 196, 176, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN I546V MUTANT IN COMPLEX WITH THE FUNCTION BLOCKING FAB NMC4
128, 1oakA, 0.5987, 3.20, 0.125, 196, 176, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN IN COMPLEX WITH THE FUNCTION BLOCKING NMC-4 FAB
129, 6epdW, 0.5980, 2.83, 0.070, 195, 172, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
130, 3jcoFA, 0.5977, 3.06, 0.103, 197, 175, 
131, 1ijbA, 0.5977, 3.25, 0.125, 202, 176, THE VON WILLEBRAND FACTOR MUTANT (I546V) A1 DOMAIN
132, 5mpbIA, 0.5973, 2.93, 0.087, 197, 173, 
133, 3q3gL, 0.5973, 2.87, 0.116, 189, 172, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
134, 4c2bC, 0.5971, 3.24, 0.125, 199, 176, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION IN COMPLEX WITH HIGH AFFINITY GPIB ALPHA
135, 6gym4, 0.5969, 3.42, 0.093, 297, 182, STRUCTURE OF A YEAST CLOSED COMPLEX WITH DISTORTED DNA (CCDIST) 
136, 3hxoA, 0.5968, 3.23, 0.114, 199, 176, CRYSTAL STRUCTURE OF VON WILLEBRAND FACTOR (VWF) A1 DOMAIN IN COMPLEX WITH DNA APTAMER ARC1172 AN INHIBITOR OF VWF-PLATELET BINDING
137, 5bv8A, 0.5962, 3.27, 0.119, 209, 176, G1324S MUTATION IN VON WILLEBRAND FACTOR A1 DOMAIN
138, 6fvtCA, 0.5961, 2.91, 0.098, 197, 173, struct.pdbx_descriptor              
139, 4c2aA, 0.5959, 3.29, 0.119, 202, 176, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH R1306Q AND I1309V MUTATIONS IN COMPLEX WITH HIGH AFFINITY GPIB ALPHA
140, 3q3gG, 0.5958, 2.90, 0.122, 189, 172, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
141, 3hxqA, 0.5958, 3.27, 0.125, 201, 176, CRYSTAL STRUCTURE OF VON WILLEBRAND FACTOR (VWF) A1 DOMAIN IN COMPLEX WITH DNA APTAMER ARC1172 AN INHIBITOR OF VWF-PLATELET BINDING
142, 1uexC, 0.5958, 3.26, 0.125, 202, 176, CRYSTAL STRUCTURE OF VON WILLEBRAND FACTOR A1 DOMAIN COMPLEXED WITH SNAKE VENOM BITISCETIN
143, 1auqA, 0.5958, 3.28, 0.125, 208, 176, A1 DOMAIN OF VON WILLEBRAND FACTOR
144, 4c2bG, 0.5955, 3.26, 0.125, 197, 176, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION IN COMPLEX WITH HIGH AFFINITY GPIB ALPHA
145, 3q3gE, 0.5953, 2.91, 0.116, 189, 172, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
146, 1ijkA, 0.5953, 3.26, 0.114, 199, 176, THE VON WILLEBRAND FACTOR MUTANT (I546V) A1 DOMAIN- BOTROCETIN COMPLEX
147, 4c2bA, 0.5952, 3.29, 0.125, 199, 176, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION IN COMPLEX WITH HIGH AFFINITY GPIB ALPHA
148, 6j30RA, 0.5951, 3.12, 0.103, 197, 175, struct.pdbx_descriptor              
149, 6j2cRA, 0.5951, 3.09, 0.103, 197, 175, struct.pdbx_descriptor              
150, 1m10A, 0.5947, 3.19, 0.120, 199, 175, CRYSTAL STRUCTURE OF THE COMPLEX OF GLYCOPROTEIN IB ALPHA AND THE VON WILLEBRAND FACTOR A1 DOMAIN
151, 3q3gI, 0.5946, 2.93, 0.116, 189, 172, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
152, 1u0oC, 0.5945, 3.25, 0.114, 195, 176, THE MOUSE VON WILLEBRAND FACTOR A1-BOTROCETIN COMPLEX
153, 1na5A, 0.5945, 2.96, 0.121, 195, 173, INTEGRIN ALPHA M I DOMAIN
154, 4c29A, 0.5933, 3.19, 0.126, 201, 175, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION
155, 5oqm4, 0.5932, 3.33, 0.083, 297, 180, STRUCTURE OF YEAST TRANSCRIPTION PRE-INITIATION COMPLEX WITH TFIIH AND CORE MEDIATOR 
156, 5oqj4, 0.5932, 3.33, 0.083, 297, 180, STRUCTURE OF YEAST TRANSCRIPTION PRE-INITIATION COMPLEX WITH TFIIH 
157, 4c29B, 0.5932, 3.29, 0.125, 201, 176, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION
158, 1mf7A, 0.5930, 3.01, 0.121, 194, 173, INTEGRIN ALPHA M I DOMAIN
159, 4cr2W, 0.5929, 2.90, 0.082, 197, 170, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
160, 4c2bE, 0.5929, 3.32, 0.119, 199, 176, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION IN COMPLEX WITH HIGH AFFINITY GPIB ALPHA
161, 1u0nA, 0.5928, 3.28, 0.114, 207, 176, THE TERNARY VON WILLEBRAND FACTOR A1-GLYCOPROTEIN IBALPHA- BOTROCETIN COMPLEX
162, 5l4kW, 0.5926, 3.07, 0.070, 196, 172, THE HUMAN 26S PROTEASOME LID
163, 5es4A, 0.5925, 3.10, 0.115, 1080, 174, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
164, 4igiA, 0.5925, 2.96, 0.116, 197, 172, CRYSTAL STRUCTURE OF THE COLLAGEN VI ALPHA3 N5 DOMAIN
165, 4f1kA, 0.5920, 3.09, 0.071, 200, 170, CRYSTAL STRUCTURE OF THE MG2+ FREE VWA DOMAIN OF PLASMODIUM FALCIPARUM TRAP PROTEIN
166, 4f1jA, 0.5920, 3.10, 0.071, 200, 170, CRYSTAL STRUCTURE OF THE MG2+ LOADED VWA DOMAIN OF PLASMODIUM FALCIPARUM TRAP PROTEIN
167, 6j2nRA, 0.5917, 3.15, 0.109, 197, 175, struct.pdbx_descriptor              
168, 4f1kB, 0.5917, 3.11, 0.071, 200, 170, CRYSTAL STRUCTURE OF THE MG2+ FREE VWA DOMAIN OF PLASMODIUM FALCIPARUM TRAP PROTEIN
169, 4f1jB, 0.5914, 3.12, 0.071, 200, 170, CRYSTAL STRUCTURE OF THE MG2+ LOADED VWA DOMAIN OF PLASMODIUM FALCIPARUM TRAP PROTEIN
170, 4hqkA, 0.5908, 3.12, 0.065, 200, 170, CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM TRAP P4212 FORM
171, 5mpdW, 0.5904, 3.06, 0.086, 197, 174, 26S PROTEASOME IN PRESENCE OF ATP (S1)
172, 5gjrP, 0.5904, 3.09, 0.092, 193, 173, 
173, 5gjrJB, 0.5904, 3.09, 0.092, 193, 173, 
174, 4ihkA, 0.5904, 3.01, 0.105, 193, 172, CRYSTAL STRUCTURE OF THE COLLAGEN VI ALPHA3 N5 DOMAIN R1061Q
175, 5gjqW, 0.5902, 3.10, 0.098, 193, 173, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
176, 3tw0B, 0.5902, 4.54, 0.111, 361, 199, STRUCTURAL ANALYSIS OF ADHESIVE TIP PILIN GBS104 FROM GROUP B STREPTOCOCCUS AGALACTIAE
177, 5ln1A, 0.5899, 3.03, 0.099, 188, 171, STRUCTURE OF UBIQUITYLATED-RPN10 FROM YEAST;
178, 3tw0A, 0.5898, 4.59, 0.110, 361, 200, STRUCTURAL ANALYSIS OF ADHESIVE TIP PILIN GBS104 FROM GROUP B STREPTOCOCCUS AGALACTIAE
179, 3qa3G, 0.5898, 2.90, 0.112, 187, 170, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
180, 4hqkB, 0.5891, 3.13, 0.071, 199, 170, CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM TRAP P4212 FORM
181, 3k71G, 0.5890, 3.14, 0.115, 1082, 174, STRUCTURE OF INTEGRIN ALPHAX BETA2 ECTODOMAIN
182, 4wfqA, 0.5888, 2.83, 0.089, 192, 169, CRYSTAL STRUCTURE OF TFIIH SUBUNIT
183, 3tw0C, 0.5888, 4.61, 0.105, 360, 200, STRUCTURAL ANALYSIS OF ADHESIVE TIP PILIN GBS104 FROM GROUP B STREPTOCOCCUS AGALACTIAE
184, 3k6sA, 0.5884, 3.14, 0.115, 1082, 174, STRUCTURE OF INTEGRIN ALPHAXBETA2 ECTODOMAIN
185, 6nmiE, 0.5880, 2.97, 0.110, 366, 172, CRYO-EM STRUCTURE OF THE HUMAN TFIIH CORE COMPLEX 
186, 5a5bW, 0.5878, 3.16, 0.109, 197, 174, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
187, 4cr3W, 0.5878, 3.16, 0.109, 197, 174, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
188, 1jlmA, 0.5875, 2.92, 0.118, 187, 170, I-DOMAIN FROM INTEGRIN CR3 MN2+ BOUND
189, 3tw0D, 0.5873, 4.57, 0.095, 357, 199, STRUCTURAL ANALYSIS OF ADHESIVE TIP PILIN GBS104 FROM GROUP B STREPTOCOCCUS AGALACTIAE
190, 1n3yA, 0.5865, 3.09, 0.110, 189, 172, CRYSTAL STRUCTURE OF THE ALPHA-X BETA2 INTEGRIN I DOMAIN
191, 1bhq2, 0.5864, 3.14, 0.116, 189, 172, MAC-1 I DOMAIN CADMIUM COMPLEX
192, 1bho1, 0.5864, 3.14, 0.128, 189, 172, MAC-1 I DOMAIN MAGNESIUM COMPLEX
193, 1bhq1, 0.5863, 3.13, 0.116, 189, 172, MAC-1 I DOMAIN CADMIUM COMPLEX
194, 1idn2, 0.5860, 3.14, 0.116, 189, 172, MAC-1 I DOMAIN METAL FREE
195, 5vgzb, 0.5857, 3.15, 0.076, 191, 171, CONFORMATIONAL LANDSCAPE OF THE P28-BOUND HUMAN PROTEASOME REGULATORY PARTICLE
196, 6mskH, 0.5856, 3.12, 0.093, 191, 172, struct.pdbx_descriptor               26S proteasome  
197, 6o9m6, 0.5855, 3.08, 0.121, 385, 173, STRUCTURE OF THE HUMAN APO TFIIH 
198, 1bho2, 0.5853, 3.15, 0.116, 189, 172, MAC-1 I DOMAIN MAGNESIUM COMPLEX
199, 5obzA, 0.5852, 3.46, 0.101, 200, 178, LOW RESOLUTION STRUCTURE OF THE P34CT/P44CT MINIMAL COMPLEX
200, 3ppvA, 0.5848, 2.71, 0.091, 184, 165, CRYSTAL STRUCTURE OF AN ENGINEERED VWF A2 DOMAIN (N1493C AND C1670S)
201, 5wvkRA, 0.5844, 3.24, 0.103, 197, 175, 
202, 6j2qRA, 0.5843, 3.15, 0.088, 197, 171, struct.pdbx_descriptor              
203, 3ppxA, 0.5842, 2.72, 0.091, 184, 165, CRYSTAL STRUCTURE OF THE N1602A MUTANT OF AN ENGINEERED VWF A2 DOMAIN (N1493C AND C1670S)
204, 6epeW, 0.5841, 3.05, 0.070, 195, 172, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
205, 3ppwA, 0.5841, 2.71, 0.091, 184, 165, CRYSTAL STRUCTURE OF THE D1596A MUTANT OF AN ENGINEERED VWF A2 DOMAIN (N1493C AND C1670S)
206, 1idn1, 0.5840, 3.18, 0.122, 189, 172, MAC-1 I DOMAIN METAL FREE
207, 3ppyA, 0.5834, 2.72, 0.091, 187, 165, CRYSTAL STRUCTURE OF THE D1596A/N1602A DOUBLE MUTANT OF AN ENGINEERED VWF A2 DOMAIN (N1493C AND C1670S)
208, 6msjH, 0.5827, 3.00, 0.094, 191, 170, struct.pdbx_descriptor               26S proteasome  
209, 5nusA, 0.5827, 3.21, 0.092, 210, 174, STRUCTURE OF A MINIMAL COMPLEX BETWEEN P44 AND P34 FROM CHAETOMIUM THERMOPHILUM
210, 3qa3I, 0.5827, 2.89, 0.113, 185, 168, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
211, 6ro4D, 0.5826, 3.19, 0.110, 280, 173, STRUCTURE OF THE CORE TFIIH-XPA-DNA COMPLEX 
212, 6o9l6, 0.5821, 2.85, 0.113, 385, 168, HUMAN HOLO-PIC IN THE CLOSED STATE 
213, 4pn7A, 0.5817, 3.27, 0.097, 209, 175, CRYSTAL STRUCTURE OF THE TFIIH P34 N-TERMINAL DOMAIN
214, 5iy73, 0.5815, 3.28, 0.109, 193, 175, HUMAN HOLO-PIC IN THE OPEN STATE
215, 5iy63, 0.5815, 3.28, 0.109, 193, 175, HUMAN HOLO-PIC IN THE CLOSED STATE
216, 5iy93, 0.5814, 3.28, 0.109, 193, 175, HUMAN HOLO-PIC IN THE INITIAL TRANSCRIBING STATE (NO IIS)
217, 5iy83, 0.5814, 3.28, 0.109, 193, 175, HUMAN HOLO-PIC IN THE INITIAL TRANSCRIBING STATE
218, 5ivw3, 0.5811, 3.29, 0.109, 193, 175, HUMAN CORE TFIIH BOUND TO DNA WITHIN THE PIC
219, 3qa3E, 0.5805, 2.95, 0.113, 186, 168, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
220, 5oqm6, 0.5804, 3.21, 0.092, 335, 174, STRUCTURE OF YEAST TRANSCRIPTION PRE-INITIATION COMPLEX WITH TFIIH AND CORE MEDIATOR 
221, 5oqj6, 0.5804, 3.21, 0.092, 335, 174, STRUCTURE OF YEAST TRANSCRIPTION PRE-INITIATION COMPLEX WITH TFIIH 
222, 6mseH, 0.5802, 2.96, 0.065, 191, 168, struct.pdbx_descriptor               26S proteasome  
223, 5vfqV, 0.5801, 3.03, 0.077, 191, 169, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
224, 5vhfb, 0.5799, 3.24, 0.082, 191, 171, CONFORMATIONAL LANDSCAPE OF THE P28-BOUND HUMAN PROTEASOME REGULATORY PARTICLE
225, 5vhhb, 0.5797, 3.25, 0.088, 191, 171, CONFORMATIONAL LANDSCAPE OF THE P28-BOUND HUMAN PROTEASOME REGULATORY PARTICLE
226, 3qa3L, 0.5797, 3.14, 0.118, 185, 169, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
227, 5vfsV, 0.5792, 3.02, 0.071, 191, 169, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
228, 5kyyA, 0.5792, 3.62, 0.102, 716, 177, CRYSTAL STRUCTURE OF SEC23 AND TANGO1 PEPTIDE4 COMPLEX
229, 5of4E, 0.5790, 3.16, 0.110, 184, 172, THE CRYO-EM STRUCTURE OF HUMAN TFIIH
230, 5kynB, 0.5790, 3.70, 0.096, 719, 178, STRUCTURE OF SEC23 AND TANGO1 COMPLEX
231, 6bxjA, 0.5789, 3.04, 0.125, 619, 168, STRUCTURE OF A SINGLE-CHAIN BETA3 INTEGRIN 
232, 6msgH, 0.5781, 3.18, 0.088, 191, 171, struct.pdbx_descriptor               26S proteasome  
233, 5iy80, 0.5781, 3.33, 0.109, 188, 174, HUMAN HOLO-PIC IN THE INITIAL TRANSCRIBING STATE
234, 5iy70, 0.5781, 3.33, 0.109, 188, 174, HUMAN HOLO-PIC IN THE OPEN STATE
235, 5iy60, 0.5781, 3.33, 0.109, 188, 174, HUMAN HOLO-PIC IN THE CLOSED STATE
236, 5iy90, 0.5780, 3.33, 0.109, 188, 174, HUMAN HOLO-PIC IN THE INITIAL TRANSCRIBING STATE (NO IIS)
237, 6gym6, 0.5779, 3.24, 0.092, 335, 174, STRUCTURE OF A YEAST CLOSED COMPLEX WITH DISTORTED DNA (CCDIST) 
238, 5ivw0, 0.5775, 3.34, 0.109, 188, 174, HUMAN CORE TFIIH BOUND TO DNA WITHIN THE PIC
239, 5vhib, 0.5774, 3.30, 0.088, 191, 171, CONFORMATIONAL LANDSCAPE OF THE P28-BOUND HUMAN PROTEASOME REGULATORY PARTICLE
240, 5kyxA, 0.5774, 3.65, 0.096, 716, 177, CRYSTAL STRUCTURE OF SEC23 AND TANGO1 PEPTIDE1 COMPLEX
241, 6o9m4, 0.5773, 3.62, 0.112, 295, 179, STRUCTURE OF THE HUMAN APO TFIIH 
242, 6epcW, 0.5772, 3.16, 0.087, 195, 172, GROUND STATE 26S PROTEASOME (GS2)
243, 5vftb, 0.5772, 3.05, 0.077, 191, 169, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
244, 5t0hb, 0.5772, 3.05, 0.077, 191, 169, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
245, 5vhsb, 0.5770, 3.29, 0.088, 191, 171, CONFORMATIONAL LANDSCAPE OF THE P28-BOUND HUMAN PROTEASOME REGULATORY PARTICLE
246, 5wviT, 0.5769, 3.33, 0.081, 197, 172, 
247, 5kywA, 0.5769, 3.71, 0.096, 714, 178, CRYSTAL STRUCTURE OF SEC23 AND TANGO1 PEPTIDE3 COMPLEX
248, 6mshH, 0.5768, 3.19, 0.094, 191, 171, struct.pdbx_descriptor               26S proteasome  
249, 3efoA, 0.5768, 3.71, 0.096, 716, 178, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23/24 BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF SYNTAXIN 5
250, 3eg9A, 0.5767, 3.66, 0.096, 726, 177, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23/24 BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF MEMBRIN
251, 5kyuA, 0.5764, 3.71, 0.084, 716, 178, CRYSTAL STRUCTURE OF SEC23 AND TANGO1 PEPTIDE2 COMPLEX
252, 5vnhA, 0.5763, 3.68, 0.090, 707, 177, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL SV SORTING MOTIF
253, 3egxA, 0.5763, 3.73, 0.084, 708, 178, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23A/24A COMPLEXED WITH THE SNARE PROTEIN SEC22B AND BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF THE SNARE PROTEIN BET1
254, 2x5nA, 0.5763, 3.06, 0.083, 188, 168, CRYSTAL STRUCTURE OF THE SPRPN10 VWA DOMAIN
255, 6gniA, 0.5762, 3.66, 0.113, 733, 177, CRYO-TOMOGRAPHY AND SUBTOMOGRAM AVERAGING OF SAR1-SEC23-SEC24 - FITTED MODEL. 
256, 6bxbA, 0.5762, 2.97, 0.144, 463, 167, CRYSTAL STRUCTURE OF AN EXTENDED B3 INTEGRIN P33 
257, 4bziG, 0.5762, 3.66, 0.113, 733, 177, THE STRUCTURE OF THE COPII COAT ASSEMBLED ON MEMBRANES
258, 4bziD, 0.5762, 3.66, 0.113, 733, 177, THE STRUCTURE OF THE COPII COAT ASSEMBLED ON MEMBRANES
259, 4bziA, 0.5762, 3.66, 0.113, 733, 177, THE STRUCTURE OF THE COPII COAT ASSEMBLED ON MEMBRANES
260, 2qtvA, 0.5762, 3.66, 0.113, 733, 177, STRUCTURE OF SEC23-SAR1 COMPLEXED WITH THE ACTIVE FRAGMENT OF SEC31
261, 5vneA, 0.5760, 3.68, 0.090, 708, 177, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH EMP24 SORTING MOTIF
262, 4xw2A, 0.5760, 3.05, 0.143, 184, 168, STRUCTURAL BASIS FOR SIMVASTATIN COMPETITIVE ANTAGONISM OF COMPLEMENT RECEPTOR 3
263, 1m2oA, 0.5760, 3.66, 0.113, 718, 177, CRYSTAL STRUCTURE OF THE SEC23-SAR1 COMPLEX
264, 5vnoA, 0.5757, 3.75, 0.096, 703, 178, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22
265, 3egdA, 0.5753, 3.74, 0.096, 711, 178, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23A/24A COMPLEXED WITH THE SNARE PROTEIN SEC22 AND BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF VESICULAR STOMATITIS VIRUS GLYCOPROTEIN
266, 5vniA, 0.5752, 3.68, 0.090, 707, 177, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL FA SORTING MOTIF
267, 1m2oC, 0.5752, 3.67, 0.113, 718, 177, CRYSTAL STRUCTURE OF THE SEC23-SAR1 COMPLEX
268, 1m2vA, 0.5748, 3.68, 0.107, 705, 177, CRYSTAL STRUCTURE OF THE YEAST SEC23/24 HETERODIMER
269, 6j2xRA, 0.5746, 3.38, 0.099, 197, 171, struct.pdbx_descriptor              
270, 6bxfA, 0.5746, 3.00, 0.144, 463, 167, CRYSTAL STRUCTURE OF AN EXTENDED B3 INTEGRIN L33 
271, 6o9l4, 0.5745, 3.62, 0.106, 295, 180, HUMAN HOLO-PIC IN THE CLOSED STATE 
272, 5vnjA, 0.5745, 3.69, 0.096, 697, 177, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL FF SORTING MOTIF (ERGIC-53)
273, 2nupA, 0.5745, 3.68, 0.090, 699, 177, CRYSTAL STRUCTURE OF THE HUMAN SEC23A/24A HETERODIMER COMPLEXED WITH THE SNARE PROTEIN SEC22B
274, 5vnlA, 0.5744, 3.68, 0.090, 699, 177, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH 4- PHENYLBUTYRIC ACID (1MM SOAKING)
275, 2nutA, 0.5744, 3.75, 0.096, 708, 178, CRYSTAL STRUCTURE OF THE HUMAN SEC23A/24A HETERODIMER COMPLEXED WITH THE SNARE PROTEIN SEC22B
276, 5vnmA, 0.5742, 3.75, 0.096, 698, 178, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH 4- PHENYLBUTYRIC ACID (15MM SOAKING)
277, 5vnnA, 0.5741, 3.75, 0.096, 699, 178, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH 4- PHENYLBUTYRIC ACID (50MM SOAKING)
278, 5t0gb, 0.5740, 3.06, 0.077, 191, 168, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
279, 5t0cNA, 0.5740, 3.06, 0.077, 191, 168, 
280, 5t0cH, 0.5740, 3.06, 0.077, 191, 168, 
281, 5vngA, 0.5738, 3.76, 0.096, 696, 178, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL II SORTING MOTIF
282, 5vnfA, 0.5737, 3.76, 0.096, 707, 178, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL VV SORTING MOTIF
283, 6ckbA, 0.5736, 3.13, 0.143, 464, 168, CRYSTAL STRUCTURE OF AN EXTENDED BETA3 INTEGRIN P33 
284, 3zqkC, 0.5736, 2.78, 0.092, 178, 163, VON WILLEBRAND FACTOR A2 DOMAIN WITH CALCIUM
285, 1m1uA, 0.5736, 2.98, 0.143, 184, 168, AN ISOLEUCINE-BASED ALLOSTERIC SWITCH CONTROLS AFFINITY AND SHAPE SHIFTING IN INTEGRIN CD11B A-DOMAIN
286, 5kynA, 0.5732, 3.72, 0.085, 730, 177, STRUCTURE OF SEC23 AND TANGO1 COMPLEX
287, 5vnkA, 0.5731, 3.77, 0.079, 708, 178, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL LL SORTING MOTIF
288, 5vfpU, 0.5728, 3.02, 0.060, 191, 168, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
289, 3zqkA, 0.5728, 2.78, 0.092, 181, 163, VON WILLEBRAND FACTOR A2 DOMAIN WITH CALCIUM
290, 1n9zA, 0.5728, 3.07, 0.143, 184, 168, INTEGRIN ALPHA M I DOMAIN MUTANT
291, 1jeqA, 0.5726, 3.86, 0.100, 548, 180, CRYSTAL STRUCTURE OF THE KU HETERODIMER
292, 1idoA, 0.5725, 3.00, 0.143, 184, 168, I-DOMAIN FROM INTEGRIN CR3 MG2+ BOUND
293, 5vfuH, 0.5724, 3.05, 0.065, 191, 168, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
294, 5t0ib, 0.5724, 3.05, 0.065, 191, 168, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
295, 6ergA, 0.5720, 4.00, 0.104, 501, 182, COMPLEX OF XLF AND HETERODIMER KU BOUND TO DNA 
296, 6bxfB, 0.5720, 3.03, 0.138, 464, 167, CRYSTAL STRUCTURE OF AN EXTENDED B3 INTEGRIN L33 
297, 1zonA, 0.5720, 2.88, 0.145, 181, 165, CD11A I-DOMAIN WITHOUT BOUND CATION
298, 6msdH, 0.5715, 3.08, 0.077, 191, 169, struct.pdbx_descriptor               26S proteasome  
299, 6ergD, 0.5714, 3.87, 0.100, 503, 180, COMPLEX OF XLF AND HETERODIMER KU BOUND TO DNA 
300, 5y58E, 0.5712, 4.25, 0.086, 548, 186, CRYSTAL STRUCTURE OF KU70/80 AND TLC1
301, 5of4F, 0.5711, 3.58, 0.125, 205, 176, THE CRYO-EM STRUCTURE OF HUMAN TFIIH
302, 6bxbB, 0.5710, 3.21, 0.125, 465, 168, CRYSTAL STRUCTURE OF AN EXTENDED B3 INTEGRIN P33 
303, 5y58C, 0.5710, 4.26, 0.086, 548, 186, CRYSTAL STRUCTURE OF KU70/80 AND TLC1
304, 5y58A, 0.5709, 4.26, 0.086, 548, 186, CRYSTAL STRUCTURE OF KU70/80 AND TLC1
305, 3zqkB, 0.5707, 2.70, 0.093, 178, 162, VON WILLEBRAND FACTOR A2 DOMAIN WITH CALCIUM
306, 6msbH, 0.5701, 3.12, 0.071, 191, 169, struct.pdbx_descriptor               26S proteasome  
307, 5e6sE, 0.5696, 3.29, 0.144, 580, 167, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
308, 6nmiF, 0.5694, 3.73, 0.110, 263, 181, CRYO-EM STRUCTURE OF THE HUMAN TFIIH CORE COMPLEX 
309, 6ckbB, 0.5694, 3.20, 0.125, 465, 168, CRYSTAL STRUCTURE OF AN EXTENDED BETA3 INTEGRIN P33 
310, 5t0jb, 0.5692, 3.19, 0.071, 191, 169, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
311, 6epfW, 0.5689, 3.32, 0.087, 195, 173, GROUND STATE 26S PROTEASOME (GS1)
312, 3gxbB, 0.5680, 2.93, 0.086, 177, 163, CRYSTAL STRUCTURE OF VWF A2 DOMAIN
313, 3f78C, 0.5680, 3.11, 0.133, 180, 166, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN COMPLEXED WITH ISOFLURANE
314, 6ro4E, 0.5678, 3.62, 0.107, 237, 178, STRUCTURE OF THE CORE TFIIH-XPA-DNA COMPLEX 
315, 5e6uA, 0.5678, 3.43, 0.125, 583, 168, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
316, 5e6sA, 0.5678, 3.39, 0.131, 578, 168, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
317, 3f74C, 0.5677, 3.01, 0.140, 180, 164, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN
318, 3gxbA, 0.5675, 2.94, 0.086, 177, 163, CRYSTAL STRUCTURE OF VWF A2 DOMAIN
319, 2i6qA, 0.5669, 3.83, 0.096, 503, 177, COMPLEMENT COMPONENT C2A
320, 5e6rA, 0.5663, 3.41, 0.131, 581, 168, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
321, 4m76B, 0.5661, 2.94, 0.127, 179, 165, INTEGRIN I DOMAIN OF COMPLEMENT RECEPTOR 3 IN COMPLEX WITH C3D
322, 5o85C, 0.5655, 3.48, 0.103, 198, 174, P34-P44 COMPLEX
323, 3egdB, 0.5654, 3.37, 0.071, 731, 170, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23A/24A COMPLEXED WITH THE SNARE PROTEIN SEC22 AND BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF VESICULAR STOMATITIS VIRUS GLYCOPROTEIN
324, 2odpA, 0.5652, 3.76, 0.102, 490, 176, COMPLEMENT COMPONENT C2A THE CATALYTIC FRAGMENT OF C3- AND C5- CONVERTASE OF HUMAN COMPLEMENT
325, 3f78B, 0.5650, 3.06, 0.139, 180, 165, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN COMPLEXED WITH ISOFLURANE
326, 3f74A, 0.5649, 3.04, 0.145, 180, 165, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN
327, 1pd0A, 0.5648, 3.92, 0.130, 734, 177, CRYSTAL STRUCTURE OF THE COPII COAT SUBUNIT SEC24 COMPLEXED WITH A PEPTIDE FROM THE SNARE PROTEIN SED5 (YEAST SYNTAXIN-5)
328, 5vnhB, 0.5647, 3.38, 0.071, 729, 170, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL SV SORTING MOTIF
329, 2odqA, 0.5647, 3.86, 0.096, 492, 177, COMPLEMENT COMPONENT C2A THE CATALYTIC FRAGMENT OF C3- AND C5- CONVERTASE OF HUMAN COMPLEMENT
330, 1dgqA, 0.5645, 2.99, 0.140, 188, 164, NMR SOLUTION STRUCTURE OF THE INSERTED DOMAIN OF HUMAN LEUKOCYTE FUNCTION ASSOCIATED ANTIGEN-1
331, 6gniE, 0.5644, 3.88, 0.130, 735, 177, CRYO-TOMOGRAPHY AND SUBTOMOGRAM AVERAGING OF SAR1-SEC23-SEC24 - FITTED MODEL. 
332, 4bziM, 0.5644, 3.88, 0.130, 735, 177, THE STRUCTURE OF THE COPII COAT ASSEMBLED ON MEMBRANES
333, 4bziL, 0.5644, 3.88, 0.130, 735, 177, THE STRUCTURE OF THE COPII COAT ASSEMBLED ON MEMBRANES
334, 4bziE, 0.5644, 3.88, 0.130, 735, 177, THE STRUCTURE OF THE COPII COAT ASSEMBLED ON MEMBRANES
335, 1m2vB, 0.5644, 3.88, 0.130, 748, 177, CRYSTAL STRUCTURE OF THE YEAST SEC23/24 HETERODIMER
336, 5ln3W, 0.5642, 3.02, 0.079, 185, 164, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
337, 3f74B, 0.5642, 3.01, 0.140, 180, 164, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN
338, 3f78A, 0.5641, 3.00, 0.146, 180, 164, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN COMPLEXED WITH ISOFLURANE
339, 4nehA, 0.5639, 3.34, 0.119, 1084, 168, AN INTERNAL LIGAND-BOUND METASTABLE STATE OF A LEUKOCYTE INTEGRIN AXB2
340, 1pd1A, 0.5639, 3.93, 0.130, 735, 177, CRYSTAL STRUCTURE OF THE COPII COAT SUBUNIT SEC24 COMPLEXED WITH A PEPTIDE CONTAINING THE DXE CARGO SORTING SIGNAL OF YEAST SYS1 PROTEIN
341, 1pcxA, 0.5638, 3.95, 0.130, 745, 177, CRYSTAL STRUCTURE OF THE COPII COAT SUBUNIT SEC24 COMPLEXED WITH A PEPTIDE FROM THE SNARE PROTEIN BET1
342, 5o85A, 0.5634, 3.45, 0.127, 190, 173, P34-P44 COMPLEX
343, 6erfE, 0.5627, 3.89, 0.107, 497, 178, COMPLEX OF APLF FACTOR AND KU HETERODIMER BOUND TO DNA 
344, 6erhC, 0.5626, 3.97, 0.100, 493, 180, COMPLEX OF XLF AND HETERODIMER KU BOUND TO DNA 
345, 2i6sA, 0.5626, 3.54, 0.111, 497, 171, COMPLEMENT COMPONENT C2A
346, 3ibsB, 0.5625, 3.28, 0.120, 199, 166, CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL PROTEIN BATB FROM BACTEROIDES THETAIOTAOMICRON
347, 1jeyA, 0.5624, 4.08, 0.110, 493, 182, CRYSTAL STRUCTURE OF THE KU HETERODIMER BOUND TO DNA
348, 3ibsA, 0.5621, 3.28, 0.120, 200, 166, CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL PROTEIN BATB FROM BACTEROIDES THETAIOTAOMICRON
349, 5gjvF, 0.5619, 3.29, 0.118, 941, 169, STRUCTURE OF THE MAMMALIAN VOLTAGE-GATED CALCIUM CHANNEL CAV1.1 COMPLEX AT NEAR ATOMIC RESOLUTION
350, 5e6sC, 0.5619, 3.38, 0.138, 578, 167, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
351, 2x31D, 0.5618, 2.98, 0.098, 187, 163, MODELLING OF THE COMPLEX BETWEEN SUBUNITS BCHI AND BCHD OF MAGNESIUM CHELATASE BASED ON SINGLE-PARTICLE CRYO-EM RECONSTRUCTION AT 7.5 ANG
352, 4nenA, 0.5617, 3.27, 0.120, 1063, 167, AN INTERNAL LIGAND-BOUND METASTABLE STATE OF A LEUKOCYTE INTEGRIN AXB2
353, 1mjnA, 0.5616, 3.01, 0.153, 179, 163, CRYSTAL STRUCTURE OF THE INTERMEDIATE AFFINITY AL I DOMAIN MUTANT
354, 2x31C, 0.5611, 3.08, 0.097, 187, 165, MODELLING OF THE COMPLEX BETWEEN SUBUNITS BCHI AND BCHD OF MAGNESIUM CHELATASE BASED ON SINGLE-PARTICLE CRYO-EM RECONSTRUCTION AT 7.5 ANG
355, 5gjwF, 0.5605, 3.35, 0.118, 941, 169, STRUCTURE OF THE MAMMALIAN VOLTAGE-GATED CALCIUM CHANNEL CAV1.1 COMPLEX FOR CLASSII MAP
356, 6erfC, 0.5601, 3.89, 0.107, 500, 177, COMPLEX OF APLF FACTOR AND KU HETERODIMER BOUND TO DNA 
357, 4hqoB, 0.5601, 3.55, 0.132, 260, 167, CRYSTAL STRUCTURE OF PLASMODIUM VIVAX TRAP PROTEIN
358, 5vneB, 0.5589, 3.91, 0.068, 729, 176, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH EMP24 SORTING MOTIF
359, 2x31E, 0.5586, 3.10, 0.091, 187, 164, MODELLING OF THE COMPLEX BETWEEN SUBUNITS BCHI AND BCHD OF MAGNESIUM CHELATASE BASED ON SINGLE-PARTICLE CRYO-EM RECONSTRUCTION AT 7.5 ANG
360, 4okrB, 0.5585, 2.99, 0.130, 236, 161, STRUCTURES OF TOXOPLASMA GONDII MIC2
361, 2nupB, 0.5584, 3.93, 0.074, 731, 176, CRYSTAL STRUCTURE OF THE HUMAN SEC23A/24A HETERODIMER COMPLEXED WITH THE SNARE PROTEIN SEC22B
362, 5vnnB, 0.5583, 3.92, 0.068, 731, 176, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH 4- PHENYLBUTYRIC ACID (50MM SOAKING)
363, 5vnlB, 0.5583, 3.92, 0.068, 731, 176, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH 4- PHENYLBUTYRIC ACID (1MM SOAKING)
364, 2x31B, 0.5583, 3.01, 0.092, 187, 163, MODELLING OF THE COMPLEX BETWEEN SUBUNITS BCHI AND BCHD OF MAGNESIUM CHELATASE BASED ON SINGLE-PARTICLE CRYO-EM RECONSTRUCTION AT 7.5 ANG
365, 4hqnB, 0.5581, 3.60, 0.126, 256, 167, CRYSTAL STRUCTURE OF MANGANESE-LOADED PLASMODIUM VIVAX TRAP PROTEIN
366, 1jeqB, 0.5581, 3.98, 0.063, 520, 175, CRYSTAL STRUCTURE OF THE KU HETERODIMER
367, 6erfB, 0.5578, 3.97, 0.085, 521, 176, COMPLEX OF APLF FACTOR AND KU HETERODIMER BOUND TO DNA 
368, 4hqlB, 0.5577, 3.61, 0.126, 256, 167, CRYSTAL STRUCTURE OF MAGNESIUM-LOADED PLASMODIUM VIVAX TRAP PROTEIN
369, 3egxB, 0.5577, 3.87, 0.074, 729, 175, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23A/24A COMPLEXED WITH THE SNARE PROTEIN SEC22B AND BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF THE SNARE PROTEIN BET1
370, 6erfA, 0.5575, 3.90, 0.114, 493, 176, COMPLEX OF APLF FACTOR AND KU HETERODIMER BOUND TO DNA 
371, 6cesD, 0.5574, 4.04, 0.067, 901, 179, CRYO-EM STRUCTURE OF GATOR1-RAG
372, 5y3rB, 0.5574, 3.50, 0.094, 526, 170, CRYO-EM STRUCTURE OF HUMAN DNA-PK HOLOENZYME
373, 5vniB, 0.5574, 3.92, 0.080, 727, 175, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL FA SORTING MOTIF
374, 5vngB, 0.5574, 3.96, 0.074, 728, 176, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL II SORTING MOTIF
375, 2nutB, 0.5574, 3.86, 0.074, 729, 175, CRYSTAL STRUCTURE OF THE HUMAN SEC23A/24A HETERODIMER COMPLEXED WITH THE SNARE PROTEIN SEC22B
376, 6erfF, 0.5573, 3.98, 0.085, 526, 176, COMPLEX OF APLF FACTOR AND KU HETERODIMER BOUND TO DNA 
377, 5vnjB, 0.5573, 3.94, 0.074, 731, 176, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL FF SORTING MOTIF (ERGIC-53)
378, 6erfH, 0.5572, 3.99, 0.085, 526, 176, COMPLEX OF APLF FACTOR AND KU HETERODIMER BOUND TO DNA 
379, 3eobI, 0.5572, 3.05, 0.149, 179, 161, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM II
380, 6erfD, 0.5571, 3.98, 0.085, 520, 176, COMPLEX OF APLF FACTOR AND KU HETERODIMER BOUND TO DNA 
381, 5vnfB, 0.5571, 3.83, 0.069, 729, 175, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL VV SORTING MOTIF
382, 4hqfA, 0.5569, 3.70, 0.076, 200, 171, CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM TRAP I4 FORM
383, 5vnkB, 0.5568, 3.85, 0.074, 729, 175, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL LL SORTING MOTIF
384, 3eoaI, 0.5568, 2.95, 0.150, 179, 160, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM I
385, 5vnoB, 0.5567, 3.88, 0.074, 731, 175, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22
386, 1jeyB, 0.5566, 3.98, 0.085, 530, 176, CRYSTAL STRUCTURE OF THE KU HETERODIMER BOUND TO DNA
387, 2o7nA, 0.5565, 3.26, 0.141, 180, 163, CD11A (LFA1) I-DOMAIN COMPLEXED WITH 7A-[(4-CYANOPHENYL) METHYL]-6-(35-DICHLOROPHENYL)-5-OXO-2357A-TETRAHYDRO- 1H-PYRROLO[12-A]PYRROLE-7-CARBONITRILE
388, 5vnmB, 0.5562, 3.86, 0.074, 731, 175, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH 4- PHENYLBUTYRIC ACID (15MM SOAKING)
389, 3jbrF, 0.5562, 3.47, 0.107, 872, 169, CRYO-EM STRUCTURE OF THE RABBIT VOLTAGE-GATED CALCIUM CHANNEL CAV1.1 COMPLEX AT 4.2 ANGSTROM
390, 3bqnB, 0.5562, 3.19, 0.153, 182, 163, LFA-1 I DOMAIN BOUND TO INHIBITORS
391, 3bqmB, 0.5562, 3.20, 0.153, 182, 163, LFA-1 I DOMAIN BOUND TO INHIBITORS
392, 3m6fA, 0.5561, 3.30, 0.141, 180, 163, CD11A I-DOMAIN COMPLEXED WITH 6-((5S9R)-9-(4-CYANOPHENYL)-3-(35- DICHLOROPHENYL)-1-METHYL-24-DIOXO-137- TRIAZASPIRO[4.4]NON-7-YL) NICOTINIC ACID
393, 6erfG, 0.5557, 3.90, 0.108, 495, 176, COMPLEX OF APLF FACTOR AND KU HETERODIMER BOUND TO DNA 
394, 4okuB, 0.5557, 2.98, 0.131, 241, 160, STRUCTURE OF TOXOPLASMA GONDII PROMIC2
395, 1shtX, 0.5556, 3.50, 0.142, 177, 169, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A DOMAIN OF HUMAN CAPILLARY MORPHOGENESIS PROTEIN 2: AN ANTHRAX TOXIN RECEPTOR
396, 3eoaJ, 0.5555, 3.06, 0.149, 179, 161, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM I
397, 1xuoA, 0.5555, 3.13, 0.142, 181, 162, X-RAY STRUCTURE OF LFA-1 I-DOMAIN BOUND TO A 14-DIAZEPANE- 25-DIONE INHIBITOR AT 1.8A RESOLUTION
398, 3bqnC, 0.5553, 3.19, 0.141, 182, 163, LFA-1 I DOMAIN BOUND TO INHIBITORS
399, 2x31A, 0.5553, 3.18, 0.098, 187, 164, MODELLING OF THE COMPLEX BETWEEN SUBUNITS BCHI AND BCHD OF MAGNESIUM CHELATASE BASED ON SINGLE-PARTICLE CRYO-EM RECONSTRUCTION AT 7.5 ANG
400, 2icaA, 0.5553, 3.31, 0.129, 179, 163, CD11A (LFA1) I-DOMAIN COMPLEXED WITH BMS-587101 AKA 5-[(5S 9R)-9-(4-CYANOPHENYL)-3-(35-DICHLOROPHENYL)-1-METHYL-24- DIOXO-137-TRIAZASPIRO [4.4]NON-7-YL]METHYL]-3- THIOPHENECARBOXYLICACID
401, 3hi6A, 0.5552, 3.20, 0.122, 180, 164, CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57
402, 3bqmC, 0.5551, 3.19, 0.141, 182, 163, LFA-1 I DOMAIN BOUND TO INHIBITORS
403, 6erhA, 0.5549, 3.88, 0.102, 490, 176, COMPLEX OF XLF AND HETERODIMER KU BOUND TO DNA 
404, 3e2mA, 0.5549, 3.18, 0.160, 182, 162, LFA-1 I DOMAIN BOUND TO INHIBITORS
405, 1rd4C, 0.5549, 3.16, 0.154, 184, 162, AN ALLOSTERIC INHIBITOR OF LFA-1 BOUND TO ITS I-DOMAIN
406, 3eobJ, 0.5548, 3.13, 0.154, 179, 162, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM II
407, 1rd4A, 0.5548, 3.16, 0.154, 184, 162, AN ALLOSTERIC INHIBITOR OF LFA-1 BOUND TO ITS I-DOMAIN
408, 4fx5A, 0.5547, 3.20, 0.127, 415, 166, VON WILLEBRAND FACTOR TYPE A FROM CATENULISPORA ACIDIPHILA
409, 2x31F, 0.5547, 3.08, 0.092, 187, 163, MODELLING OF THE COMPLEX BETWEEN SUBUNITS BCHI AND BCHD OF MAGNESIUM CHELATASE BASED ON SINGLE-PARTICLE CRYO-EM RECONSTRUCTION AT 7.5 ANG
410, 1zopB, 0.5547, 3.20, 0.141, 183, 163, CD11A I-DOMAIN WITH BOUND MAGNESIUM ION
411, 1zopA, 0.5547, 3.20, 0.141, 183, 163, CD11A I-DOMAIN WITH BOUND MAGNESIUM ION
412, 1zooB, 0.5547, 3.20, 0.141, 183, 163, CD11A I-DOMAIN WITH BOUND MAGNESIUM ION
413, 1zooA, 0.5547, 3.20, 0.141, 183, 163, CD11A I-DOMAIN WITH BOUND MAGNESIUM ION
414, 1rd4D, 0.5547, 3.16, 0.154, 184, 162, AN ALLOSTERIC INHIBITOR OF LFA-1 BOUND TO ITS I-DOMAIN
415, 1rd4B, 0.5547, 3.17, 0.142, 184, 162, AN ALLOSTERIC INHIBITOR OF LFA-1 BOUND TO ITS I-DOMAIN
416, 3hi6B, 0.5546, 3.11, 0.129, 180, 163, CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57
417, 1xddA, 0.5546, 3.14, 0.148, 182, 162, X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH LFA703 AT 2.2A RESOLUTION
418, 1xddB, 0.5544, 3.20, 0.154, 182, 162, X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH LFA703 AT 2.2A RESOLUTION
419, 4ixdA, 0.5540, 3.06, 0.142, 182, 162, X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH IBE-667 AT 1.8A RESOLUTION
420, 4hqoA, 0.5538, 3.44, 0.139, 257, 165, CRYSTAL STRUCTURE OF PLASMODIUM VIVAX TRAP PROTEIN
421, 4hqnA, 0.5535, 3.46, 0.133, 254, 165, CRYSTAL STRUCTURE OF MANGANESE-LOADED PLASMODIUM VIVAX TRAP PROTEIN
422, 1lfaB, 0.5535, 3.08, 0.142, 182, 162, CD11A I-DOMAIN WITH BOUND MN++
423, 4hqlA, 0.5533, 3.47, 0.121, 254, 165, CRYSTAL STRUCTURE OF MAGNESIUM-LOADED PLASMODIUM VIVAX TRAP PROTEIN
424, 1lfaA, 0.5532, 3.15, 0.148, 183, 162, CD11A I-DOMAIN WITH BOUND MN++
425, 1xuoB, 0.5530, 3.00, 0.138, 175, 159, X-RAY STRUCTURE OF LFA-1 I-DOMAIN BOUND TO A 14-DIAZEPANE- 25-DIONE INHIBITOR AT 1.8A RESOLUTION
426, 6cetD, 0.5528, 4.17, 0.067, 901, 180, CRYO-EM STRUCTURE OF GATOR1
427, 3eh1A, 0.5527, 3.92, 0.074, 737, 175, CRYSTAL STRUCTURE OF THE HUMAN COPII-COAT PROTEIN SEC24B
428, 1cqpB, 0.5524, 3.13, 0.143, 182, 161, CRYSTAL STRUCTURE ANALYSIS OF THE COMPLEX LFA-1 (CD11A) I-DOMAIN / LOVASTATIN AT 2.6 A RESOLUTION
429, 1cqpA, 0.5522, 3.24, 0.142, 182, 162, CRYSTAL STRUCTURE ANALYSIS OF THE COMPLEX LFA-1 (CD11A) I-DOMAIN / LOVASTATIN AT 2.6 A RESOLUTION
430, 6adrR, 0.5521, 3.48, 0.119, 185, 168, ANTHRAX TOXIN RECEPTOR 1-BOUND THE SENECA VALLEY VIRUS IN NEUTRAL CONDITIONS 
431, 3e2mB, 0.5520, 3.12, 0.149, 182, 161, LFA-1 I DOMAIN BOUND TO INHIBITORS
432, 1xdgA, 0.5519, 3.07, 0.144, 182, 160, X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH LFA878 AT 2.1A RESOLUTION
433, 1xdgB, 0.5517, 3.13, 0.137, 182, 161, X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH LFA878 AT 2.1A RESOLUTION
434, 5vfrb, 0.5514, 3.24, 0.072, 191, 167, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
435, 5m6wL, 0.5513, 3.97, 0.103, 505, 174, PROPERDIN IN COMPLEX WITH ALTERNATIVE PATHWAY C3 CONVERTASE
436, 1shuX, 0.5513, 3.49, 0.107, 181, 168, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A DOMAIN OF HUMAN CAPILLARY MORPHOGENESIS PROTEIN 2: AN ANTHRAX TOXIN RECEPTOR
437, 5m6wJ, 0.5506, 3.96, 0.109, 505, 174, PROPERDIN IN COMPLEX WITH ALTERNATIVE PATHWAY C3 CONVERTASE
438, 1tzno, 0.5506, 3.55, 0.107, 181, 168, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
439, 1tznm, 0.5506, 3.55, 0.107, 181, 168, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
440, 1tznl, 0.5506, 3.55, 0.107, 181, 168, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
441, 1tznk, 0.5506, 3.55, 0.107, 181, 168, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
442, 1tznj, 0.5506, 3.55, 0.107, 181, 168, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
443, 1tzni, 0.5506, 3.55, 0.107, 181, 168, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
444, 1tznh, 0.5506, 3.55, 0.107, 181, 168, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
445, 1tzng, 0.5506, 3.55, 0.107, 181, 168, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
446, 1tznf, 0.5506, 3.55, 0.107, 181, 168, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
447, 1tzne, 0.5506, 3.55, 0.107, 181, 168, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
448, 1tznd, 0.5506, 3.55, 0.107, 181, 168, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
449, 1tznc, 0.5506, 3.55, 0.107, 181, 168, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
450, 1tznb, 0.5506, 3.55, 0.107, 181, 168, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
451, 1tzna, 0.5506, 3.55, 0.107, 181, 168, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
452, 3tcxT, 0.5503, 3.23, 0.140, 180, 164, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
453, 3tcxL, 0.5503, 3.23, 0.140, 180, 164, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
454, 3tcxD, 0.5503, 3.23, 0.140, 180, 164, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
455, 3tcxb, 0.5502, 3.23, 0.140, 180, 164, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
456, 3tcxZ, 0.5502, 3.23, 0.140, 180, 164, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
457, 3tcxP, 0.5502, 3.23, 0.140, 180, 164, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
458, 3tcxN, 0.5502, 3.23, 0.140, 180, 164, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
459, 3tcxJ, 0.5502, 3.23, 0.140, 180, 164, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
460, 3tcxH, 0.5502, 3.23, 0.140, 180, 164, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
461, 3tcxF, 0.5502, 3.23, 0.140, 180, 164, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
462, 2winL, 0.5502, 3.95, 0.098, 507, 174, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
463, 2winK, 0.5502, 3.95, 0.098, 507, 174, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
464, 2winJ, 0.5502, 3.95, 0.098, 507, 174, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
465, 2winI, 0.5502, 3.95, 0.098, 507, 174, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
466, 3tcxX, 0.5501, 3.23, 0.140, 180, 164, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
467, 3tcxR, 0.5501, 3.23, 0.140, 180, 164, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
468, 3tcxB, 0.5501, 3.23, 0.140, 180, 164, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
469, 3tcxV, 0.5500, 3.23, 0.140, 180, 164, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
470, 1rs0A, 0.5488, 3.77, 0.105, 480, 171, CRYSTAL STRUCTURE ANALYSIS OF THE BB SEGMENT OF FACTOR B COMPLEXED WITH DI-ISOPROPYL-PHOSPHATE (DIP)
471, 1rtkA, 0.5482, 3.78, 0.105, 486, 171, CRYSTAL STRUCTURE ANALYSIS OF THE BB SEGMENT OF FACTOR B COMPLEXED WITH 4-GUANIDINOBENZOIC ACID
472, 6admR, 0.5480, 3.48, 0.090, 185, 166, ANTHRAX TOXIN RECEPTOR 1-BOUND FULL PARTICLES OF SENECA VALLEY VIRUS IN ACIDIC CONDITIONS 
473, 3n2nF, 0.5480, 3.51, 0.126, 185, 167, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
474, 1rrkA, 0.5479, 3.79, 0.105, 480, 171, CRYSTAL STRUCTURE ANALYSIS OF THE BB SEGMENT OF FACTOR B
475, 3n2nD, 0.5472, 3.52, 0.126, 185, 167, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
476, 4jduA, 0.5471, 2.97, 0.075, 193, 159, THE CRYSTAL STRUCTURE OF AN AEROTOLERANCE-RELATED MEMBRANE PROTEIN FROM BACTEROIDES FRAGILIS NCTC 9343 WITH MULTIPLE MUTATIONS TO SERINES.
477, 3n2nE, 0.5471, 3.53, 0.126, 185, 167, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
478, 3n2nA, 0.5470, 3.54, 0.126, 185, 167, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
479, 3n2nB, 0.5467, 3.55, 0.126, 185, 167, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
480, 2xwjK, 0.5452, 4.12, 0.104, 713, 173, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
481, 3n2nC, 0.5451, 3.45, 0.097, 185, 165, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
482, 3hs0D, 0.5448, 3.83, 0.101, 699, 169, COBRA VENOM FACTOR (CVF) IN COMPLEX WITH HUMAN FACTOR B
483, 6ergE, 0.5444, 3.79, 0.095, 536, 169, COMPLEX OF XLF AND HETERODIMER KU BOUND TO DNA 
484, 6ergB, 0.5444, 3.78, 0.095, 531, 169, COMPLEX OF XLF AND HETERODIMER KU BOUND TO DNA 
485, 2xwjJ, 0.5443, 4.04, 0.105, 713, 172, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
486, 1t6bY, 0.5437, 3.33, 0.129, 170, 163, CRYSTAL STRUCTURE OF B. ANTHRACIS PROTECTIVE ANTIGEN COMPLEXED WITH HUMAN ANTHRAX TOXIN RECEPTOR
487, 2xwjI, 0.5436, 4.15, 0.104, 712, 173, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
488, 1t0pA, 0.5434, 2.91, 0.140, 174, 157, STRUCTURAL BASIS OF ICAM RECOGNITION BY INTEGRIN ALPAHLBETA2 REVEALED IN THE COMPLEX STRUCTURE OF BINDING DOMAINS OF ICAM-3 AND ALPHALBETA2 AT 1.65 A
489, 2xwjL, 0.5433, 4.15, 0.104, 711, 173, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
490, 6erhB, 0.5432, 3.80, 0.095, 534, 169, COMPLEX OF XLF AND HETERODIMER KU BOUND TO DNA 
491, 6erhD, 0.5428, 3.82, 0.095, 535, 169, COMPLEX OF XLF AND HETERODIMER KU BOUND TO DNA 
492, 3hs0I, 0.5428, 3.86, 0.101, 704, 169, COBRA VENOM FACTOR (CVF) IN COMPLEX WITH HUMAN FACTOR B
493, 2xwbF, 0.5416, 3.90, 0.106, 714, 170, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTORS B AND D
494, 3hrzD, 0.5415, 3.92, 0.101, 693, 169, COBRA VENOM FACTOR (CVF) IN COMPLEX WITH HUMAN FACTOR B
495, 2xwbH, 0.5414, 3.89, 0.106, 711, 170, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTORS B AND D
496, 1mqaA, 0.5409, 2.94, 0.140, 174, 157, CRYSTAL STRUCTURE OF HIGH AFFINITY ALPHAL I DOMAIN IN THE ABSENCE OF LIGAND OR METAL
497, 1mq9A, 0.5402, 3.06, 0.140, 173, 157, CRYSTAL STRUCTURE OF HIGH AFFINITY ALPHAL I DOMAIN WITH LIGAND MIMETIC CRYSTAL CONTACT
498, 2ok5A, 0.5400, 3.55, 0.085, 710, 164, HUMAN COMPLEMENT FACTOR B
499, 6cx1E, 0.5389, 3.55, 0.110, 182, 164, CRYO-EM STRUCTURE OF SENECA VALLEY VIRUS-ANTHRAX TOXIN RECEPTOR 1 COMPLEX 
500, 4okrA, 0.5387, 3.36, 0.133, 235, 158, STRUCTURES OF TOXOPLASMA GONDII MIC2
501, 4okuA, 0.5370, 3.36, 0.139, 240, 158, STRUCTURE OF TOXOPLASMA GONDII PROMIC2
502, 5a8jA, 0.5367, 3.82, 0.114, 365, 166, CRYSTAL STRUCTURE OF THE ARNB PARALOG VWA2 FROM SULFOLOBUS ACIDOCALDARIUS
503, 1mq8D, 0.5361, 3.46, 0.110, 177, 164, CRYSTAL STRUCTURE OF ALPHAL I DOMAIN IN COMPLEX WITH ICAM-1
504, 1mq8B, 0.5360, 3.46, 0.110, 177, 164, CRYSTAL STRUCTURE OF ALPHAL I DOMAIN IN COMPLEX WITH ICAM-1
505, 1q0pA, 0.5294, 3.57, 0.093, 192, 161, A DOMAIN OF FACTOR B
506, 3bn3A, 0.5236, 2.72, 0.141, 180, 149, CRYSTAL STRUCTURE OF ICAM-5 IN COMPLEX WITH AL I DOMAIN
507, 2nvoA, 0.5026, 3.72, 0.115, 496, 157, CRYSTAL STRUCTURE OF DEINOCOCCUS RADIODURANS RO (RSR) PROTEIN
508, 5y3rA, 0.5013, 4.55, 0.093, 493, 172, CRYO-EM STRUCTURE OF HUMAN DNA-PK HOLOENZYME
